Bowman & CO S.C. Johnson & Johnson Transaction History

Bowman & CO S.C.

$187 Million
Q3 2024

A detailed history of Bowman & CO S.C. transactions in Johnson & Johnson stock. As of the latest transaction made, Bowman & CO S.C. holds 11,899 shares of JNJ stock, worth $1.85 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares

11,899

Previous 11,012 8.05%

Holding current value

$1.85 Million

Previous $1.61 Million 19.83%

% of portfolio

1.03%

Previous 0.95%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$145.48 - $167.38 $129,040 - $148,466	887 Added 8.05%	11,899 $1.93 Million
Q2 2024 Jul 24, 2024	BUY	$144.38 - $157.78 $137,016 - $149,733	949 Added 9.43%	11,012 $1.61 Million
Q1 2024 Apr 15, 2024	SELL	$155.22 - $162.74 $27,939 - $29,293	-180 Reduced 1.76%	10,063 $1.59 Million
Q4 2023 Jan 10, 2024	BUY	$145.6 - $158.88 $69,742 - $76,103	479 Added 4.91%	10,243 $1.61 Million
Q3 2023 Oct 04, 2023	BUY	$155.75 - $174.48 $71,177 - $79,737	457 Added 4.91%	9,764 $1.52 Million
Q2 2023 Jul 17, 2023	BUY	$154.35 - $166.11 $33,493 - $36,045	217 Added 2.39%	9,307 $1.54 Million
Q1 2023 Apr 13, 2023	BUY	$151.05 - $180.26 $321,585 - $383,773	2,129 Added 30.58%	9,090 $1.41 Million
Q4 2022 Jan 20, 2023	BUY	$160.2 - $179.79 $64,240 - $72,095	401 Added 6.11%	6,961 $0
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $34,685 - $38,596	215 Added 3.39%	6,560 $1.07 Million
Q2 2022 Jul 29, 2022	BUY	$168.19 - $186.01 $111,173 - $122,952	661 Added 11.63%	6,345 $1.13 Million
Q1 2022 Apr 29, 2022	BUY	$158.14 - $179.59 $158,298 - $179,769	1,001 Added 21.38%	5,684 $1.01 Million
Q4 2021 Jan 31, 2022	BUY	$155.93 - $173.01 $730,220 - $810,205	4,683 New	4,683 $799,000

Others Institutions Holding JNJ

# of Institutions

4,271

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $407B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bowman & CO S.C., based on Form 13F filings with the SEC.

News

Stay updated on Bowman & CO S.C. with notifications on news.

Account